2025-07-20 - Analysis Report
Okay, here's an analysis of Procter & Gamble (PG) based on the provided data, formatted as requested.

**Report: Procter & Gamble (PG) Stock Analysis**

**1. Relative Performance Analysis**

*   **Ticker:** PG
*   **Company:** Procter & Gamble Co.
*   **Description:** Procter & Gamble is a multinational consumer goods corporation.
*   **PG Cumulative Return:** 48.80%
*   **VOO (S&P 500) Cumulative Return:** 96.72%
*   **Performance Divergence:**
    *   Current Divergence: -48.4%
    *   Max Divergence: 29.9%
    *   Min Divergence: -49.9%
    *   Relative Divergence: 1.9% (This indicates PG is currently positioned near the bottom end of its historical divergence range compared to VOO).

**Alpha/Beta Analysis:**

| Year       | CAGR   | MDD    | Alpha  | Beta  | Cap(B) |
|------------|--------|--------|--------|-------|--------|
| 2015-2017  | 21.0%  | 7.9%   | -8.0%  | 0.0   | 215.4  |
| 2016-2018  | 5.0%   | 56.7%  | -13.0% | 0.1   | 215.5  |
| 2017-2019  | 30.0%  | 56.7%  | 0.0%   | 0.5   | 292.8  |
| 2018-2020  | 38.0%  | 59.1%  | 18.0%  | 0.3   | 326.2  |
| 2019-2021  | 56.0%  | 59.1%  | 8.0%   | 0.3   | 383.5  |
| 2020-2022  | 24.0%  | 74.7%  | 22.0%  | 0.3   | 355.3  |
| 2021-2023  | 30.0%  | 74.7%  | 12.0%  | 0.3   | 343.6  |
| 2022-2024  | 8.0%   | 74.7%  | -17.0% | 0.3   | 393.1  |
| 2023-2025  | -11.0% | 71.6%  | -60.0% | 0.2   | 363.6  |

*   **Analysis:**
    *   PG has significantly underperformed the S&P 500 based on cumulative returns.
    *   The Relative Divergence of 1.9% suggests PG is near the bottom of its relative performance range versus the S&P 500.
    *   Beta values are consistently low (0.0 to 0.5), indicating PG's price is not strongly correlated with the broader market.
    *   Alpha values are mixed, with some periods showing outperformance (positive Alpha) and others showing underperformance (negative Alpha).  The most recent period (2023-2025) shows a significant negative Alpha.
    *   MDD is generally High, but the CAGR is low.

**2. Recent Stock Price Movement**

*   **Current Price:** 155.10
*   **Last Market Data:** Price = 155.1, Previous Close = 154.563, Change = 0.35
*   **5-day Moving Average:** 154.32
*   **20-day Moving Average:** 158.13
*   **60-day Moving Average:** 161.15

*   **Analysis:** The current price is below the 20-day and 60-day moving averages but above the 5-day moving average.  This could signal a potential short-term uptrend after a longer-term downtrend. The small 'change' value suggests relatively stable price action in the very recent past.

**3. Technical Indicators**

*   **Market Risk Indicator (MRI):** 0.34 (Low Risk)
*   **RSI:** 35.14 (Approaching Oversold)
*   **PPO:** -0.20 (Negative but close to zero, suggesting weak downtrend)
*   **Hybrid Signal:** Cash_0%_Buy 80% of cash (6 shares - Caution - MRI:0.34)
*   **Recent (20-day) Relative Divergence Change:** 1.9 (+): Short-term rise
*   **Expected Return (%):** 403.3% (Excess return compared to S&P 500 based on long-term investment from current levels)

*   **Analysis:**
    *   The MRI suggests a low level of overall market risk, which is a positive factor.
    *   The RSI of 35.14 is nearing oversold territory (typically below 30), which *could* indicate a potential buying opportunity. However, it's important to consider this in conjunction with other indicators.
    *   The PPO is negative but close to zero, suggesting a weak downtrend.
    *   The Hybrid Signal suggests buying shares, but with caution.
    *   The high Expected Return (%) should be viewed cautiously. Such high returns are unlikely to be sustained.

**4. Recent News & Significant Events**

*   **[2025-07-16]:** Major business developments, regulatory changes, or market events.
*   **[2025-07-19]:** Analyst discussions regarding recent performance and outlook.
*   **[2025-07-20]:** Notable stock volatility.
*   **[2025-07-18]:** Market experts highlight both risks and opportunities.

*   **Analysis:** The recent news suggests increased scrutiny of PG's performance, potential volatility, and the need for investors to stay informed about company announcements and market events.

**5. Recent Earnings Analysis**

| 날짜       | EPS   | 매출      |
|------------|-------|-----------|
| 2025-04-24 | 1.58  | 19.78 B$  |
| 2025-01-22 | 1.94  | 21.88 B$  |
| 2024-10-18 | 1.65  | 21.74 B$  |
| 2024-04-19 | 1.56  | 20.20 B$  |
| 2025-04-24 | 1.56  | 20.20 B$  |

*   **Analysis:**  Revenue and EPS have fluctuated over the past few quarters. There is a noticeable drop in Revenue and EPS in the most recent quarter (2025-04-24).

**6. Financial Information**

**Revenue and Profitability:**

| Quarter      | Revenue    | Profit Margin |
|--------------|------------|---------------|
| 2025-03-31   | $19.78B    | 50.98%        |
| 2024-12-31   | $21.88B    | 52.39%        |
| 2024-09-30   | $21.74B    | 52.06%        |
| 2024-06-30   | $20.53B    | 49.60%        |
| 2024-03-31   | $20.20B    | 51.20%        |

**Capital and Profitability:**

| Quarter      | Equity     | ROE    |
|--------------|------------|--------|
| 2025-03-31   | $52.27B    | 7.21%  |
| 2024-12-31   | $51.17B    | 9.05%  |
| 2024-09-30   | $51.84B    | 7.64%  |
| 2024-06-30   | $50.29B    | 6.24%  |
| 2024-03-31   | $50.06B    | 7.50%  |

*   **Analysis:**
    *   Revenue has shown some fluctuation over the past year, with a recent dip in the latest quarter.
    *   Profit margins are relatively stable, consistently around 50-52%.
    *   Equity has been steadily increasing.
    *   ROE (Return on Equity) has fluctuated, generally following the trend of revenue and profit margins.

**7. Overall Summary & Analysis**

Procter & Gamble (PG) has underperformed the S&P 500 over the period examined. While the Market Risk Indicator is low and the RSI is approaching oversold, suggesting potential value, several factors raise concerns.  Recent news points to increased volatility and scrutiny. Recent earning shows lower Revenue and EPS and the recent Alpha/Beta Analysis table indicates the CAGR is low and MDD is high. The hybrid signal is caution.

**Recommendation:**  Given the mixed signals, a cautious approach is warranted. Investors should closely monitor upcoming earnings reports, company announcements, and market developments. The high expected return seems unrealistic and needs careful scrutiny. Further research into the factors causing the recent underperformance is crucial before making any investment decisions. Waiting for a clearer indication of a turnaround in performance and a more positive trend in revenue and earnings is advisable.
